Read More Pharma Industry News GSK dodges tariffs with a massive pricing pivot—but what’s the catch? GlaxoSmithKline cuts drug prices in the U.S. and secures tariff relief under a new federal deal. Find out what this means for pharma's future pricing playbook. byVenkateshDecember 30, 2025